Press release - 26 June 2007
CapMan invests in healthcare provider Nacka Närsjukhus Proxima
Funds managed by CapMan will, together with management, acquire Swedish Nacka Närsjukhus Proxima AB, a private healthcare provider offering specialised healthcare in the greater Stockholm area.
Nacka Närsjukhus Proxima is a modern healthcare provider that offers specialised healthcare services from emergency unit to complex surgery within various specialities, such as orthopaedics. The company serves primarily the greater Stockholm area and the Stockholm County Council as well as other county councils in Sweden. The company was founded in 2000 by the management and personnel and is owned prior to the transaction by Nacka Läkarkonsortium AB och Praktikertjänst AB. Net sales totalled approx. EUR 19.3 million (SEK 178.6 million) in 2006.
“There is a growing need for healthcare services primarily driven by the aging population. Nacka Närsjukhus Proxima is a well managed and established healthcare service provider and our goal is to, together with the management team, build the company into a full-scale healthcare service provider preserving high quality as a starting point,” says CapMan Buyout Partner Mats Gullbrandsson.
“The company is lead by an experienced, knowledgeable and driven management team with a long track record in medicine and healthcare,” says Björn Nordenvall, CapMan’s Partner and former CEO of private hospital Sophiahemmet.
“We are very pleased that CapMan, with their experience and network, will become a major shareholder in Nacka Närsjukhus Proxima. The investment provides us an opportunity to invest in Nacka Närsjukhus’ further growth and development”, states Monika Jansson, CEO and a founder of Nacka Närsjukhus Proxima.
The transaction will be made for a new company. CapMan funds will hold approximately 80 % of the company’s shares and the management team the remainder of the shares. The investment in the company is made by CapMan Buyout VIII and CapMan Life Science IV funds, in which CapMan Plc is a substantial investor. The transaction requires the approval of the competition authorities and it is expected to be finalised by August.
For more information, please contact:
Mats Gullbrandsson, Partner, CapMan Buyout, tel. +46 8 545 854 81 or +46 734 40 84 88
Björn Nordenvall, Partner, CapMan Life Science, tel. +46 8 545 854 70 or +46 706 391 010
Monika Jansson, CEO, Nacka Närsjukhus Proxima, tel. +46 8 601 53 01 or +46 707 61 53 01
‹ Back to previous page